Christopher Pannucci

Plastic surgeon with interest in breast recon, microsurgery, and aesthetics. Research in DVT/PE prevention, enoxaparin metabolism, and VTE risk stratification.

[James Phillips, MD, FACEP @DrPhillipsMD]

Our new article in @NEJM today on resource allocation. An extremely difficult topic that we wish did not require consideration but is important that we prepare ourselves. @GWHospital @ACEPNow @AliRaja_MD @Medscape @meganranney https://t.co/Dh14pddil4

[Christopher Pannucci @PannucciMD]

@raindancers12 @raindancers12 —I have more thoughts about your questions than I can fit in a tweet. Happy to chat if you send me your number

[Christopher Pannucci @PannucciMD]

An article of interest for #ASCRS19 attendees since it builds on @fascrs_updates consensus statement on VTE!

https://t.co/frCrIuE8p2

[Huntsman Cancer Institute @huntsmancancer]

HCI and @UofUHealth surgeon @PannucciMD will be joining @NYUDocs live on SiriusXM 110 at 4pm MST. He'll be speaking about deep venous thrombosis and pulmonary embolus in plastic surgery patients, focusing on how to understand and minimize patients' risk. Tune in!

[Christopher Pannucci @PannucciMD]

As the University of Utah's on call hand surgeon this July 4--I agree. Be safe with fireworks this weekend! https://t.co/yrtiRCTTBH

[Michigan Surgery @UMichSurgery]

Firework injuries are on the rise. A tough situation requiring multidisciplinary care. Be safe this holiday weekend. https://t.co/EDXDHYDxL2

[Christopher Pannucci @PannucciMD]

Standard enoxaparin prophylaxis (40 qday) is inadequate for the majority of patients, and inadequate dose predicts VTE. PMID 28350685. #vte

[Christopher Pannucci @PannucciMD]

Thanks Steve Haase for giving grand rounds and furthering the Michigan-Utah connection!

[Christopher Pannucci @PannucciMD]

VTE risk stratification with Caprini scores identifies the 25% of patients who benefit from chemoprophylaxis--and the 75% who may not. https://t.co/cUmWRO19V7

[Annals of Surgery @AnnalsofSurgery]

Venous Thromboembolism Risk Stratification to Identify Benefits & Harms of Chemoprophylaxis in Surgical Patients https://t.co/9RmJeVD2uv